Document is current
Any future updates will be listed below
-
Authors
Kaur, Ishwarpreet
Suri, Vanita
Sachdeva, Naresh
Rana, Satya Vati
Medhi, Bikas
Sahni, Nancy
Ahire, Jayesh
Singh, Amarjeet https://orcid.org/0000-0003-0978-0907
-
Clinical Trials BETA
Clinical trials referenced in this document:
ctri/2016/07/007086 at Clinical Trials Registry IndiaDocuments that mention this clinical trial
-
Funding
Funding for this research was provided by:
Indian Council of Medical Research (3/1/3/JRF-2013/HRD-040(10175))
- License Information
-
More Information
Article History
Received: 13 April 2022
Accepted: 8 July 2022
First Online: 20 July 2022
Declarations
:
: JJA is working in Unique Biotech Limited which manufactures probiotics; he states that the study was conducted independently at the hospital site with no intervention from him. IK, VS, NS, SVR, BM, NS, and AS do not have any conflict to declare.
: This study was approved by PGIMER Ethics Committee, Chandigarh (Ref. No. INT/IEC/2015/616, dated 13 October 2015) and conducted accordance with the principles of Indian Council of Medical Research, Declaration of Helsinki (Brazil 2013) and recommendations on Good Clinical and Laboratory Practices. This trial was registered prospectively under the Clinical Trial Registry of India (CTRI: CTRI/2016/07/007086, dated 13 July 2016).
: Informed consent was obtained from all individual participants included in the study.
: The authors confirmed that human research participant provided informed consent for publication of the images in Fig. S1.
